[unable to retrieve full-text content]Reuters - U.S. drug regulators may have a hard time stopping millions of overweight Americans from taking a new obesity drug that many are likely to view as a miracle pill for slimming waistlines, despite its safety risks.
Source: http://us.rd.yahoo.com/dailynews/rss/weightloss/*http%3A//news.yahoo.com/s/nm/20120228/hl_nm/us_clamor
lord monckton andy kaufman october 21 2011 ohio ohio john beck john beck
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.